Summary & Overview
CPT 0516T: Wireless Left Ventricular Electrode Implantation for Heart Failure
CPT code 0516T covers implantation of a wireless electrode affixed to the inside wall of the left ventricle as part of a wireless cardiac stimulator system for left ventricular pacing in patients with congestive heart failure. The code captures a specialized device-based therapy that can influence care pathways for advanced heart failure management and has implications for device coverage, facility resource use, and procedural coding consistency nationally. Key payers reflected in the discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical procedure and its coding identity, an outline of typical sites of service and service type, and what to expect in payer coverage considerations. The publication summarizes common modifiers and practical billing contexts, highlights benchmarking and coverage themes where available, and provides a clinical framing to aid coding accuracy and reimbursement discussions. Data not available in the input for some specifics (such as associated taxonomies, ICD-10 pairings, or related codes) is noted where applicable.
Billing Code Overview
CPT code 0516T describes the insertion of a wireless electrode attached to the inside wall of the left ventricle as a component of a wireless cardiac stimulator system for left ventricular pacing to treat congestive heart failure. This procedure is a form of device-based cardiac therapy intended to provide left ventricular pacing support for patients with heart failure who may benefit from targeted intraventricular stimulation.
-
Service type: Implantation of a cardiac implantable wireless electrode for left ventricular pacing
-
Typical site of service: Hospital inpatient or hospital outpatient setting; may also occur in specialized cardiac catheterization or electrophysiology procedure suites
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with ischemic cardiomyopathy and symptomatic heart failure (NYHA class III) is evaluated for device-based left ventricular resynchronization. Medical therapy including guideline-directed pharmacologic treatment and optimization of volume status has been attempted but the patient continues to have exertional dyspnea, reduced exercise tolerance, and left ventricular ejection fraction below 35%. The electrophysiology team schedules a transcatheter implantation of a wireless left ventricular endocardial pacing electrode as part of a wireless cardiac stimulator system for left ventricular pacing to treat congestive heart failure.
The procedure is typically performed in a cardiac catheterization laboratory or hybrid operating room under conscious sedation or general anesthesia depending on comorbidities and operator preference. Vascular access is obtained (commonly femoral venous and arterial access as indicated), intracardiac imaging (fluoroscopy and often transesophageal echocardiography) and heparin anticoagulation are used. The provider advances delivery catheters into the left ventricle via transseptal or arterial approach, deploys a wireless electrode and attaches it to the endocardial wall of the left ventricle, and verifies stable fixation and electrical capture. The implanted electrode is paired with the wireless cardiac stimulator system and device programming is performed prior to recovery. Post-procedure monitoring includes telemetry for arrhythmia detection, imaging to exclude pericardial effusion or lead displacement, and anticoagulation management as indicated. Typical site of service is the cardiac catheterization laboratory or hybrid OR in an inpatient or outpatient hospital setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|